Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Left ventricular function after myocardial infarction.

¹Department of Medicine, University of Minnesota Medical School, Minneapolis.

Journal of Cardiovascular Pharmacology

|January 1, 1989

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study.

Journal of human hypertension·2012

Same author

Rationale for angiotensin II receptor blocker therapy in chronic heart failure.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2007

Same author

Relationship between C-reactive protein and arterial stiffness in an asymptomatic population.

Journal of human hypertension·2005

Same author

Angiotensin receptor blockers and clinical trials in heart failure.

European heart journal·2003

Same author

Small and large artery elasticity indices in peripheral arterial occlusive disease (PAOD).

Vascular medicine (London, England)·2002

Same author

Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination.

Congestive heart failure (Greenwich, Conn.)·2002

Same journal

Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

Journal of cardiovascular pharmacology·2026

Same journal

A Comprehensive Review of PCSK9 Inhibitor Therapy.

Journal of cardiovascular pharmacology·2026

Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026

Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026

Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026

Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026

See all related articles

Vasodilator therapy can improve left ventricular dysfunction after myocardial infarction. It benefits long-term prognosis with systolic dysfunction but not diastolic dysfunction.

Area of Science:

Cardiology
Cardiovascular Medicine

Background:

Acute myocardial infarction often leads to elevated left ventricular filling pressures due to systolic and/or diastolic dysfunction.
The extent of left ventricular dysfunction is affected by infarct characteristics and systemic responses like neurohormonal changes.

Purpose of the Study:

To evaluate the impact of short-term and chronic vasodilator therapy on left ventricular dysfunction and long-term prognosis following acute myocardial infarction.

Main Methods:

The study likely involved analyzing patient data or clinical trials assessing vasodilator treatment efficacy.
Outcomes measured included left ventricular function (systolic and diastolic) and long-term patient prognosis.

Main Results:

Short-term vasodilator therapy demonstrated improvement in left ventricular dysfunction.

Related Experiment Videos

A favorable long-term prognosis was observed with this therapy in cases of severe systolic dysfunction, but not with predominant diastolic dysfunction.

Chronic vasodilator therapy also showed benefits for persistent systolic dysfunction.

Conclusions:

Vasodilator therapy is a key treatment for managing left ventricular dysfunction post-myocardial infarction.
Therapeutic strategies should differentiate between systolic and diastolic dysfunction for optimal long-term outcomes.